Since 1984, dermatologist Steven Greene has served as a clinical associate professor of medicine at the University of Washington School of Medicine in Seattle. Additionally, Dr. Greene practiced dermatology for 27 years at Group Health Permanente. An expert in aesthetic medicine, Dr. Steven Greene has a special interest in the treatment of aging skin with soft-tissue fillers and neuromodulator injections. Minimally invasive therapies in facial rejuvenation provide patients with nonsurgical options in the treatment of aging skin. These therapies have become popular because they cost less than comprehensive procedures and healing is quicker. One of these treatments is a procedure using a combination of soft-tissue fillers and neuromodulator injections. Fillers add volume to thinning skin while neuromodulators block nerve impulses, thereby relaxing and weakening the muscles so that lines retreat and the face becomes “rejuvenated.” Depending upon the patient, the procedure improves the appearance of wrinkles, crow’s feet, and other skin imperfections for a temporary period of six months to two years. In this procedure, a dermatologist uses a soft-tissue filler, such as Juvederm or Restylane, in combination with a neuromodulator injection, such as Botox. In the first stage of the treatment, the dermatologist marks injection points on the patient’s face. The doctor then cleanses the face with an anti-bacterial solution. Next, the dermatologist applies a local anesthesia, a topical agent, or ice to minimize discomfort when the filler is injected. In the second stage of the procedure, the doctor proceeds with the neuromodulator injection of the substance into the underlying muscle. This results in a relaxation and a smoothing of the overlying skin.
As a practicing dermatologist and associate professor within his specialty , Dr. Steven Greene actively pursues developments in his field. Dr. Steven Greene demonstrates expertise in the use of neuromodulators and other similar techniques that fight skin aging. This and other aesthetic techniques are offered at Advanced Dermatology and Laser Institute of Seattle. Neromodulation refers to the injection of certain compounds, such as Botox, Dysport and Xeomin, that relax and smooth wrinkles in the skin. For many people, these wrinkles come from a lifetime of facial expressions. Facial expression is controlled by muscles under the skin that relax and contract, and it is these contractions that eventually cause wrinkles in the forehead and around the eyes. The neuromodulator works by relaxing these muscles. This effect curbs the movement of the skin located above these muscles, thus allowing the skin to restructure itself and become smoother. In time, existing lines fade and new skin grows within this smoother structure. Neuromodulation works best on wrinkles in the upper part of the face, as these are the most likely to be caused by facial movement. It most often requires multiple treatments, as the effect of the injected compounds is temporary and must be reapplied. Candidates who feel they might be a good fit for this treatment should consult with a qualified dermatologist.
Clinical dermatologist Steven Greene, MD, cared for patients for nearly 27 years at the Group Health Cooperative in Seattle, Washington, until retiring in 2011. As a highly experienced professional in both diagnostic and therapeutic dermatology, Dr. Steven Greene has often used phototherapy to treat a wide range of skin disorders. In the field of dermatology, phototherapy refers to the use of ultraviolet light to treat skin diseases and disorders. When UVA/UVB light is applied, it better regulates the body’s immune system and helps to prevent a hyperactive immune response that may cause inflammation. Phototherapy works by retarding or reducing the proliferation of skin cells, which has been proven to improve or clear up dermatitis, vitiligo, psoriasis, and eczema; prevent bacterial infections stemming from eczema; and reduce the need for treatment with creams or ointments. Several sessions of phototherapy may be required before any improvement in skin condition becomes noticeable. However, after several weeks of treatment, patients normally experience less inflammation and more balanced, healthy skin.
Section Chief 1990-1996
Internal Medicine Internship
Extensive Training in Diagnostic and Therapeutic Dermatology and Dermatopathology
Undergraduate Scholars Program